Skip to main content
. 2023 Nov 29;209(4):390–401. doi: 10.1164/rccm.202308-1436OC

Table 1.

Distribution of BDR and Discrimination Statistics, by Physician-assigned Diagnosis for Different BDR Definitions

    Asthma and COPD (n = 833)   Asthma vs. COPD
BDR Definition Asthma (n = 3,519) COPD (n = 2,436) AUC (95% CI) Sensitivity, Specificity
ΔFEV1 or ΔFVC ⩾12% and ⩾200 ml 631/3,196 (19.7%) 224/757 (29.6%) 552/2,239 (24.7%) 0.597 (0.572, 0.622) 0.55, 0.30
ΔFEV1 ⩾12% and ⩾200 ml 548/3,229 (17.0%) 179/760 (23.6%) 317/2,242 (14.1%) 0.659 (0.629, 0.690) 0.58, 0.21
ΔFVC ⩾12% and ⩾200 ml 298/3,228 (9.2%) 143/758 (18.9%) 409/2,256 (18.1%) 0.592 (0.562, 0.622) 0.42, 0.43
ΔFEV1 ⩾15% and ⩾400 ml 228/3,229 (7.1%) 42/760 (5.5%) 52/2,242 (2.3%) 0.727 (0.652, 0.803) 0.80, 0.07
ΔFEV1 >10% pred 482/3,176 (15.2%) 114/750 (15.2%) 177/2,207 (8.0%) 0.571 (0.555, 0.586) 0.15, 0.92
ΔFVC >10% pred 279/3,175 (8.8%) 130/748 (17.4%) 326/2,221 (14.7%) 0.578 (0.562, 0.593) 0.09, 0.86
ΔFEV1 or ΔFVC >10% pred 569/3,143 (18.1%) 174/747 (23.3%) 396/2,204 (18.0%) 0.505 (0.490, 0.521) 0.18, 0.82
High-likelihood asthma or COPD (1) Asthma HL (n = 1,820)   COPD HL (n = 1,260) AUC (95% CI) Sensitivity, Specificity
ΔFEV1 or ΔFVC ⩾12% and ⩾200 ml 351/1,658 (21.2%)   338/1,222 (27.7%) 0.619 (0.586, 0.652) 0.54, 0.26
ΔFEV1 ⩾12% and ⩾200 ml 313/1,681 (18.6%)   176/1,223 (14.4%) 0.703 (0.664, 0.742) 0.56, 0.17
ΔFVC ⩾12% and ⩾200 ml 153/1,676 (9.1%)   260/1,227 (21.2%) 0.602 (0.562, 0.642) 0.42, 0.40
ΔFEV1 ⩾15% and ⩾400 ml 148/1,681 (8.8%)   24/1,223 (2.0%) 0.765 (0.673, 0.857) 0.80, 0.04
ΔFEV1 >10% pred 275/1,652 (16.6%)   89/1,203 (7.4%) 0.592 (0.572, 0.613) 0.16, 0.93
ΔFVC >10% pred 134/1,647 (8.1%)   210/1,207 (17.4%) 0.614 (0.593, 0.635) 0.08, 0.83
ΔFEV1 or ΔFVC >10% pred 315/1,629 (19.3%)   242/1,202 (20.1%) 0.508 (0.487, 0.530) 0.19, 0.80

Definition of abbreviations: AUC = area under the curve; BDR = bronchodilator responsiveness; CI = confidence interval; COPD = chronic obstructive pulmonary disease; HL = high likelihood; ROC = receiver operating characteristic; pred = predicted.

Δ denotes the difference between the pre- and post-bronchodilator values. This table shows the distribution of BDR for different BDR definitions across patients diagnosed with asthma and/or COPD (top) and among patients with high-likelihood asthma or COPD (bottom). The last column displays results from a ROC curve analysis evaluating the ability to discriminate between asthma-only and COPD-only patients (1). High-likelihood asthma was defined as physician diagnosis of asthma only, asthma symptom onset before age 40, and less than 5 pack-years of smoking exposure. High-likelihood COPD was defined as physician diagnosis of COPD only, COPD symptom onset at age greater than 40, at least 10 pack-years smoking exposure, and post-bronchodilator FEV1/FVC <0.7.